Načítá se...
Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies
Tumor-targeted therapies such as trastuzumab have led to significant improvements in survival of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, these therapies have also been associated with significant left ventricular dysfunction. The incidence of trastuzumab-indu...
Uloženo v:
| Vydáno v: | Methodist Debakey Cardiovasc J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Methodist Hospital Houston, Texas
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977568/ https://ncbi.nlm.nih.gov/pubmed/31988685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-15-4-250 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|